Skip to content

Karen Lynn Porte, MD.

NPI 1184688178ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Joplin, MO

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD.) in Joplin, Missouri, licensed in OK, with an NPI issued in April 2006. Part D covered 337 prescriptions written in 2024, 90% of them generic. Boehringer Ingelheim Pharmaceuticals, Inc. reported $50.52 in payments in 2024, mostly food and beverage.

Overview

NPI1184688178
StatusActive
Entity typeIndividual
CredentialMD.
Sole proprietorNo
NPI issuedApr 14, 2006
Last updated in NPPESMar 25, 2022
Certified by providerMar 25, 2022

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (MO)

Part D prescriptions in 2024

Prescriptions (claims)337 · 885 30-day fills
Patients33
Total drug cost$4,735
Generic share90% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$50.52 · 2 payments from 1 company

Top paying companies in 2024

CompanyAmountPayments
Boehringer Ingelheim Pharmaceuticals, Inc.$50.522

What the 2024 payments were for

  • Food and Beverage$50.52 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Joplin

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Missouri →